Published in Hepatitis Weekly, January 10th, 2005
RFA "is an evolving technology used to treat unresectable liver tumors," scientists in Tennessee explained. "Currently, there is no accurate method to determine RFA margins in real-time during the procedure."
C.D. Anderson and colleagues at Vanderbilt University "hypothesized that a fiber-optic based spectroscopic monitoring system could detect thermal damage from RFA in real-time." In their study, "[f]luorescence (F) and diffuse reflectance (Rd) spectra were continuously acquired from within the expected ablation zone during canine hepatic RFA using a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.